NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX)
Post# of 231
(Total Views: 305)
Posted On: 02/04/2021 3:26:40 PM
NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Joins Millions to Recognize World Cancer Day
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it joins with millions of healthcare advocates around the world in support of World Cancer Day. The designation seeks to raise awareness, elevate public understanding of the global cancer burden, promote greater equity and ensure that cancer control continues to be a priority in the world health and development agenda. “At Genprex, our primary focus is on the patients and communities we serve. Toward that end, we are relentless in our pursuit to bring innovative and life-saving oncology treatments to patients suffering with cancers for which there are limited or no treatment options,” said Rodney Varner, CEO of Genprex. “This World Cancer Day, we extend great appreciation to our research colleagues around the world who are working to alleviate the global cancer burden and to the patients who graciously offer their support through participation in clinical trials in the hope of finding new and effective treatments, not only for themselves, but for those who come after them.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it joins with millions of healthcare advocates around the world in support of World Cancer Day. The designation seeks to raise awareness, elevate public understanding of the global cancer burden, promote greater equity and ensure that cancer control continues to be a priority in the world health and development agenda. “At Genprex, our primary focus is on the patients and communities we serve. Toward that end, we are relentless in our pursuit to bring innovative and life-saving oncology treatments to patients suffering with cancers for which there are limited or no treatment options,” said Rodney Varner, CEO of Genprex. “This World Cancer Day, we extend great appreciation to our research colleagues around the world who are working to alleviate the global cancer burden and to the patients who graciously offer their support through participation in clinical trials in the hope of finding new and effective treatments, not only for themselves, but for those who come after them.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)